Guitteny A F, Herbert J M
Haemobiology Research Department, Sanofi Recherche, Toulouse, France.
Eur J Pharmacol. 1997 May 30;327(2-3):157-62. doi: 10.1016/s0014-2999(97)89655-0.
The effect of heparin on thrombin receptor expression was evaluated in an experimental model of myointimal smooth muscle cell proliferation in rabbits. Myointimal hyperplasia was induced by an air-drying injury of the carotid artery and thrombin receptor expression following endothelial injury was measured by in situ hybridisation and immunohistochemistry. In healthy arteries, thrombin receptor mRNA and protein were detected in the endothelial cells only. In contrast, 14 days after endothelial injury, thrombin receptor mRNA expression increased in the smooth muscle cells present in the neointima, predominantly in areas of active cell proliferation. A 2-week subcutaneous treatment with heparin (10 mg/kg per day, s.c.) inhibited smooth muscle cell hyperplasia occurring in the intima following deendothelialization (80 +/- 7.8% inhibition, P < 0.001). The 14-day heparin treatment strongly reduced thrombin receptor gene and protein expression observed in the endothelial cells in healthy arteries but did not affect thrombin receptor expression which occurred in smooth muscle cells which have proliferated in the neointima as a consequence of endothelial injury. These results therefore establish that thrombin receptor expression during intimal hyperplasia is an heparin-insensitive event.
在兔肌内膜平滑肌细胞增殖的实验模型中评估了肝素对凝血酶受体表达的影响。通过颈动脉风干损伤诱导肌内膜增生,并采用原位杂交和免疫组织化学方法检测内皮损伤后凝血酶受体的表达。在健康动脉中,仅在内皮细胞中检测到凝血酶受体mRNA和蛋白。相反,内皮损伤14天后,新生内膜中存在的平滑肌细胞中凝血酶受体mRNA表达增加,主要在活跃细胞增殖区域。皮下给予肝素2周(每天10mg/kg,皮下注射)可抑制去内皮化后内膜中发生的平滑肌细胞增生(抑制率80±7.8%,P<0.001)。肝素治疗14天可显著降低健康动脉内皮细胞中观察到的凝血酶受体基因和蛋白表达,但不影响因内皮损伤而在新生内膜中增殖的平滑肌细胞中发生的凝血酶受体表达。因此,这些结果表明内膜增生过程中凝血酶受体表达是一个对肝素不敏感的事件。